Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRD5A1 | P18405 | 1/20 | 0.36 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.36 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.31 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.31 |
| ▸ | ACHE | P22303 | 2/20 | 0.31 |
| ▸ | RET | P07949 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16994469 | 0.72 | PTAFR (0.38) | SRD5A1SRD5A2MTNR1AMTNR1BACHE | |
| SCHEMBL14930622 | 0.67 | CTDSP1 (0.36) | ACHERET | |
| SCHEMBL16994470 | 0.64 | PDGFRB (0.40) | ACHE | |
| SCHEMBL14903985 | 0.62 | MTNR1A (0.33) | MTNR1AMTNR1B | |
| SCHEMBL12074762 | 0.57 | PDE10A (0.43) | ACHE | |
| SCHEMBL12075017 | 0.56 | PDGFRB (0.67) | — | |
| SCHEMBL14906990 | 0.56 | MTNR1A (0.42) | MTNR1AMTNR1BACHE | |
| SCHEMBL12074886 | 0.56 | SLC2A1 (0.57) | — | |
| SCHEMBL1542350 | 0.55 | ALDH1A1 (0.50) | — | |
| SCHEMBL19683672 | 0.54 | PGR (0.60) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130109713-A1 | ANTIMICROBIAL AGENTS | UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY | 2013-05-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130109713-A1 | ANTIMICROBIAL AGENTS | RPS4X, RPS4Y1, MRPL21 | SRD5A1 2052/4885SRD5A2 2919/4885MTNR1A 1533/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.